11/28/2017 - 2:17pm

Under the new structure, the global generics and specialty medicines groups will be integrated into a single commercial organization covering North America, Europe and growth markets. Each region will manage the entire portfolio from OTC to specialty and generic pharmaceuticals. 

11/28/2017 - 1:48pm

The company noted that the relaunched generic potassium chloride powder would be available with a new NDC number.

11/27/2017 - 12:47pm

Perrigo has introduced its generics of Mycolog II Cream (nystatin and triamcinolone acetonide cream, 1 mg/gram) and the Exalgo (hydromorphone HCl) extended-release tablets in 32-mg dosage strength.

11/22/2017 - 12:59pm

The contraceptive had U.S. brand and generic sales of roughly $116.8 million, according to data from IQVIA for the 12 months ended September 2017.

11/22/2017 - 10:49am

The drug is indicated to treat attention deficit hyperactivity disorder as a monotherapy and as adjunctive treatment to stimulants. 

11/20/2017 - 10:38am

The product and its generics had U.S. sales of roughly $825 million for the 12 months ended September 2017, according to IQVIA data.

11/16/2017 - 4:40pm

Drug Store News sat down with Chester “Chip” Davis, president and CEO of the Association for Accessible Medicines, to discuss how the generics industry is adapting to a changing market, and new opportunities manufacturers may be looking to pursue.

11/16/2017 - 4:30pm

Patent expirations on branded drugs are the generics industry’s bread and butter — and the years to come hold a lot of promise.

11/16/2017 - 4:21pm

Even as more approvals roll in and industry officials talk about how biosimilars will bring significant savings in the coming decade, there is a concern that regulatory and reimbursement hurdles could prevent the industry from realizing the full savings of the less-expensive alternative to biologics.